ONL-1204 - CAS 2040964-58-5

ONL-1204 is a small molecule, CD95 antigen inhibitor (Fas inhibitor) being developed by ONL Therapeutics for the treatment of retinal detachment.

Fatty Acid Synthase, Others

Others, Metabolism

2040901

C71H100N18O16

1461.66

[C@H](CC1=CC=C(O)C=C1)(C(N[C@H](C(N[C@@H](CC2=CC=C(O)C=C2)C(N)=O)=O)[C@H](CC)C)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@H](CC3=CC=C(O)C=C3)NC([C@@H](NC([C@H](CC4=CN=CN4)NC([C@H](CC5=CN=CN5)N)=O)=O)[C@H](CC)C)=O)=O)CC(C)C)=O)=O)C)=O)[C@@H](C)C)=O)CC(N)=O)=O

-20°C

Ice Packs

Small Compound